141 related articles for article (PubMed ID: 10991968)
1. Effects of agonist-antagonist opioids in humans trained in a hydromorphone/not hydromorphone discrimination.
Preston KL; Bigelow GE
J Pharmacol Exp Ther; 2000 Oct; 295(1):114-24. PubMed ID: 10991968
[TBL] [Abstract][Full Text] [Related]
2. Drug discrimination assessment of agonist-antagonist opioids in humans: a three-choice saline-hydromorphone-butorphanol procedure.
Preston KL; Bigelow GE
J Pharmacol Exp Ther; 1994 Oct; 271(1):48-60. PubMed ID: 7525929
[TBL] [Abstract][Full Text] [Related]
3. Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination.
Preston KL; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1992 Apr; 261(1):62-71. PubMed ID: 1373189
[TBL] [Abstract][Full Text] [Related]
4. Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure.
Jones HE; Bigelow GE; Preston KL
J Pharmacol Exp Ther; 1999 Jun; 289(3):1350-61. PubMed ID: 10336526
[TBL] [Abstract][Full Text] [Related]
5. Drug discrimination in human postaddicts: agonist-antagonist opioids.
Preston KL; Bigelow GE; Bickel WK; Liebson IA
J Pharmacol Exp Ther; 1989 Jul; 250(1):184-96. PubMed ID: 2473187
[TBL] [Abstract][Full Text] [Related]
6. Three-choice drug discrimination in opioid-dependent humans: hydromorphone, naloxone and saline.
Preston KL; Bigelow GE; Bickel W; Liebson IA
J Pharmacol Exp Ther; 1987 Dec; 243(3):1002-9. PubMed ID: 2447262
[TBL] [Abstract][Full Text] [Related]
7. Drug discrimination in human post-addicts: agonist/antagonist opioids.
Preston K; Bigelow G; Bickel W; Liebson I
NIDA Res Monogr; 1988; 81():209-15. PubMed ID: 2457160
[No Abstract] [Full Text] [Related]
8. Assessment of buprenorphine in a drug discrimination procedure in humans.
Bigelow GE; Preston KL
NIDA Res Monogr; 1992; 121():28-37. PubMed ID: 1406908
[TBL] [Abstract][Full Text] [Related]
9. Opioid drug discrimination in humans: stability, specificity and relation to self-reported drug effect.
Bickel WK; Bigelow GE; Preston KL; Liebson IA
J Pharmacol Exp Ther; 1989 Dec; 251(3):1053-63. PubMed ID: 2481029
[TBL] [Abstract][Full Text] [Related]
10. Discriminative stimulus effects of opioids in pigeons trained to discriminate fentanyl, bremazocine and water: evidence of pharmacological selectivity.
Picker MJ; Cook CD
Behav Pharmacol; 1997 Jun; 8(2-3):160-73. PubMed ID: 9833011
[TBL] [Abstract][Full Text] [Related]
11. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.
Picker MJ; Yarbrough J; Hughes CE; Smith MA; Morgan D; Dykstra LA
J Pharmacol Exp Ther; 1993 Aug; 266(2):756-67. PubMed ID: 8394915
[TBL] [Abstract][Full Text] [Related]
12. Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure.
Picker MJ
J Pharmacol Exp Ther; 1994 Mar; 268(3):1190-8. PubMed ID: 8138931
[TBL] [Abstract][Full Text] [Related]
13. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
Preston KL; Bigelow GE; Liebson IA
J Pharmacol Exp Ther; 1989 Mar; 248(3):929-37. PubMed ID: 2467983
[TBL] [Abstract][Full Text] [Related]
14. Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans.
Walsh SL; Sullivan JT; Preston KL; Garner JE; Bigelow GE
J Pharmacol Exp Ther; 1996 Nov; 279(2):524-38. PubMed ID: 8930154
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with hydromorphone, a mu-opioid agonist, does not alter the acute behavioral and physiological effects of ethanol in humans.
Rush CR
Alcohol Clin Exp Res; 2001 Jan; 25(1):9-17. PubMed ID: 11198720
[TBL] [Abstract][Full Text] [Related]
16. Differential naltrexone antagonism of hydromorphone and pentazocine effects in human volunteers.
Preston KL; Bigelow GE
J Pharmacol Exp Ther; 1993 Feb; 264(2):813-23. PubMed ID: 7679737
[TBL] [Abstract][Full Text] [Related]
17. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
Strain EC; Preston KL; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
[TBL] [Abstract][Full Text] [Related]
18. Opioid discrimination in humans: discriminative and subjective effects of progressively lower training dose.
Preston KL; Bigelow GE
Behav Pharmacol; 1998 Nov; 9(7):533-43. PubMed ID: 9862079
[TBL] [Abstract][Full Text] [Related]
19. Discrimination of butorphanol and nalbuphine in opioid-dependent humans.
Preston KL; Bigelow GE; Liebson IA
Pharmacol Biochem Behav; 1990 Nov; 37(3):511-22. PubMed ID: 1708145
[TBL] [Abstract][Full Text] [Related]
20. Assessment of agonist and antagonist effects of tramadol in opioid-dependent humans.
Carroll CP; Walsh SL; Bigelow GE; Strain EC; Preston KL
Exp Clin Psychopharmacol; 2006 May; 14(2):109-20. PubMed ID: 16756415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
